Browsing Centre for Translational Medicine & Therapeutics by Author "Azevedo Loiola, R"
Now showing items 1-2 of 2
-
Identification of AnnexinA1 as an endogenous regulator of RhoA, and its role in the pathophysiology and experimental therapy of type-2 diabetes.
SOLITO, E; PURVIS, GSD; Collino, M; Azevedo Loiola, R; Baragetti, A; Chiazza, F; Brovelli, M; Collotta, D; Sheikh, M; Cento, A (Frontiers Media, 2019-03-27)Annexin A1 (ANXA1) is an endogenously produced anti-inflammatory protein, which plays an important role in the pathophysiology of diseases associated with chronic inflammation. We demonstrate that patients with type-2 ... -
Reduced Annexin A1 Expression Associates with Disease Severity and Inflammation in Multiple Sclerosis Patients.
Colamatteo, A; Maggioli, E; Azevedo Loiola, R; Hamid Sheikh, M; Calì, G; Bruzzese, D; Maniscalco, GT; Centonze, D; Buttari, F; Lanzillo, R (2019-10-01)Chronic neuroinflammation is a key pathological hallmark of multiple sclerosis (MS) that suggests that resolution of inflammation by specialized proresolving molecules is dysregulated in the disease. Annexin A1 (ANXA1) is ...